USE OF OXANTEL, MORANTEL OR THIABENDAZOLE FOR PREVENTING, INHIBITING OR REDUCING A P. GINGIVALIS BIOFILM

Abstract

Disclosed is the use of an inhibiting agent in the preparation of a pharmaceutical composition for preventing, inhibiting or treating a P. gingivalis infection in a subject, wherein the inhibiting agent prevents, inhibits or reduces a P. gingivalis biofilm and is selected from the group consisting of oxantel, morantel or thiabendazole.